Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients

Biol Psychiatry. 2012 Dec 1;72(11):e27-8. doi: 10.1016/j.biopsych.2012.05.031. Epub 2012 Jul 6.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antidepressive Agents / therapeutic use*
  • Brain-Derived Neurotrophic Factor / genetics*
  • Cross-Over Studies
  • Depressive Disorder / drug therapy*
  • Depressive Disorder / genetics*
  • Double-Blind Method
  • Female
  • Humans
  • Ketamine / therapeutic use*
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide*
  • Treatment Outcome

Substances

  • Antidepressive Agents
  • Brain-Derived Neurotrophic Factor
  • Ketamine